Media-OutReach Newswire As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
Media-OutReach Newswire Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore